Rebecca Price, PhD, Receives Society of Biological Psychiatry A.E. Bennett Award
We are thrilled to announce that Rebecca Price, PhD (Associate Professor of Psychiatry and Psychology), has received the 2023 Society of Biological Psychiatry A.E. Bennett Award for Clinical/Translational Research. This award recognizes superb international research in biological psychiatry by young investigators.
Dr. Price uses functional magnetic resonance imaging (fMRI), pupillometry, eye tracking, and neurocognitive tasks to study the mechanisms of mood and anxiety disorders. Her goal is to specify neurocognitive mechanisms relevant to affective symptoms, and then to target these mechanisms in patients using innovative methods to provide symptom relief that is both efficient and enduring. An emerging leader in cognitive neuroscience, she has also tested novel interventions for depression, suicidality, and anxiety. Dr. Price conducted the first randomized controlled trial for ketamine applied to suicidal patients, the first studies to combine neuromodulatory and/or ketamine infusion with novel cognitive bias training computer tasks, and the first study to use a novel statistical classification system for detecting data-driven subgroups of individuals using neural functional connectivity data.
“Dr. Price is an outstanding scientist whose innovative research approach has resulted in important contributions to the fields of psychiatry and cognitive neuroscience. She is remarkably creative, highly collaborative, and a superb mentor” said David Lewis, MD (Chair, Department of Psychiatry). “The impressive trajectory of Dr. Price’s research accomplishments augurs well for her continued success as a scientist and international thought leader.”
Please join us in congratulating Dr. Price!